# Han Han‐Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/han-han-zhang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,881 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 30 |
| i10-index | 49 |
| OpenAlex ID | https://openalex.org/A5041709423 |
| Works | 128 |

## Researcher papers

- [Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy](https://scholariq.org/papers/unique-genetic-profiles-from-cerebrospinal-fluid-cell-free-dna-in-leptomeningeal/)
- [Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning](https://scholariq.org/papers/ultrasensitive-detection-of-circulating-tumour-dna-via-deep-methylation/)
- [Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance](https://scholariq.org/papers/lung-adenocarcinoma-harboring-egfr-t790m-and-in-trans-c797s-responds-to/)
- [Capture-Based Targeted Ultradeep Sequencing in Paired Tissue and Plasma Samples Demonstrates Differential Subclonal ctDNA-Releasing Capability in Advanced Lung Cancer](https://scholariq.org/papers/capture-based-targeted-ultradeep-sequencing-in-paired-tissue-and-plasma-samples/)
- [Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort](https://scholariq.org/papers/circulating-tumor-dna-clearance-predicts-prognosis-across-treatment-regimen-in-a/)
- [A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity](https://scholariq.org/papers/a-phase-2-randomised-controlled-trial-of-mazdutide-in-chinese-overweight-adults/)
- [Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer](https://scholariq.org/papers/acquired-i-met-i-y1248h-and-d1246n-mutations-mediate-resistance-to-met/)
- [The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients](https://scholariq.org/papers/the-association-between-braf-mutation-class-and-clinical-features-in-braf-mutant/)
- [A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung](https://scholariq.org/papers/a-multicenter-analysis-of-genomic-profiles-and-pd-l1-expression-of-primary/)
- [Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts](https://scholariq.org/papers/characterization-of-frequently-mutated-cancer-genes-in-chinese-breast-tumors-a/)
- [Clinical outcomes of various resistance mechanisms of osimertinib in Chinese advanced non-small cell lung cancer patients.](https://scholariq.org/papers/clinical-outcomes-of-various-resistance-mechanisms-of-osimertinib-in-chinese/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.